Antiviral stocks rose in early trading, with the top nine biological trading limits

Survival Rules for Turbulent Times: A Compilation of the 20 Most Unmissable Core Insights from the 2026 Tsinghua PBCSF Forum

A dialogue between Zhu Min, former Deputy Governor of the People's Bank of China and former Vice Managing Director of the International Monetary Fund; Michael Spence, 2001 Nobel Prize winner in Economics and Philip H. Knight Professor Emeritus of Management at Stanford Graduate School of Business; and Masaaki Shirakawa, former Governor of the Bank of Japan, at the 2026 Tsinghua PBCSF Global Finance Forum.

Kanghong’s Conbercept Receives Marketing Authorization in Guyana

Kanghong Pharmaceutical (康弘药业) said its subsidiary Kanghong Bioscience had received a drug registration certificate from Guyana’s Food and Drug Department for conbercept ophthalmic injection, marketed under the brand name Lumitin (朗沐).

SHEIN Reportedly Targets US$26–27 Billion Valuation in Hong Kong IPO

SHEIN (希音), the China-founded global fashion and lifestyle retailer, is reportedly seeking a valuation of US$26 billion to US$27 billion in a planned Hong Kong initial public offering, a sharp reduction from the US$98.2 billion private-market valuation disclosed for its 2022 fundraising round.

TikTok Shop’s US Online-Spending Share Reaches 2%, Consumer Edge Data Show

TikTok Shop accounted for about 2% of US online retail spending in July, exceeding the estimated online spending captured by Target, Costco and Home Depot, according to Consumer Edge transaction data cited by Chinese e-commerce outlet Ebrun.

Blokees’ Overseas Revenue Surges 228.5% as Building Toys Gain Global Traction

Chinese building-toy company Blokees (布鲁可) reported on Aug. 12 that its overseas revenue reached CNY 366 million in the first half of 2026, up 228.5% year on year, as the company expanded its distribution and licensed-IP product portfolio across the Americas and Southeast Asia.